Medidata Solutions, a provider of clinical trial solutions, today announced the launch of Medidata Developer Central, a Web-based community that supports developers? efforts to integrate their clinical trial solutions with Medidata Rave, an electronic data capture (EDC), clinical data management (CDM), and reporting system.
MEDIDATA SOLUTIONS LAUNCHES ONLINE DEVELOPER COMMUNITY TO FOSTER COLLABORATIVE INNOVATION
Medidata Developer Central Supports Developers Using the Medidata Rave Web Services API
to Independently Build New Integrations with the Medidata Rave Platform
NEW YORK, N.Y. – October 27, 2008 – Medidata Solutions, a leading provider of clinical trial solutions, today announced the launch of Medidata Developer Central, a Web-based community that supports developers’ efforts to integrate their clinical trial solutions with Medidata Rave®, an industry-leading electronic data capture (EDC), clinical data management (CDM) and reporting system. This unique online venue provides a collaborative environment where innovative technology and service providers, as well as sponsors, can gain expertise to integrate solutions – such as interactive voice response (IVR), electronic patient reported outcomes (ePRO) and clinical trial management tools – with Medidata Rave. Developer Central simplifies the development path and makes it easy for sponsors of clinical research to extend Rave’s core platform capabilities to maximize the value of their current and future technology investments.
The launch of Medidata Developer Central extends the support of Medidata’s Rave Web Services API, which Medidata made available in June to enable independent, rapid and cost-effective integrations so that customers can enjoy a seamless eClinical environment with real-time, inbound and outbound data sharing using industry standards. Medidata Rave offers industry-leading clinical systems interoperability with its standards-based design – a design that has exclusively earned Rave CDISC certification for all eight operational data model (ODM) use cases.
Medidata created Developer Central in response to the growing demand from technology providers and contract research organizations (CROs) to integrate other technology solutions with Medidata Rave. Developer Central also addresses the industry’s rising number of IT developers relying on Web-based tools and online communities for their software development. A number of developers from clinical technology providers have already joined Medidata Developer Central as pilot members, including individuals from the following innovative companies:
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.